Evidence comes from: Clinical trials Case reports Adverse event databases Retrospective studies Each type of investigation provides useful insight, but is also associated with important limitations that we must consider
In addition, she described the distribution of the GLP-1 receptors (GLP-1R) and which ones may be accessible to systemic GLP-1R agonists
Neurons use ATP to maintain membrane potentials, release and recycle neurotransmitters, transport proteins along axons, maintain synapses and recover after each electrical signal
This review highlights key clinical considerations across reproductive stages, emphasizes the primacy of human exposure data where available, and identifies critical evidence gaps requiring future prospective study
Tirzepatide, a dual GLP-1/GIP receptor agonist, has a shorter half-life of approximately 5 days but achieves sustained receptor activation through extended tissue binding